Nomura Holdings’s Clarus Therapeutics Holdings, Inc. Warrants CRXTW Stock Holding History

Nomura Holdings’s Portfolio CRXTW Stock Details CRXTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-85,000	Closed	–	–	2016
2022 Q3	$0	Hold	85,000	–	–	﹤0.01%	2078
2022 Q2	$11K	Hold	85,000	–	–	﹤0.01%	1660
2022 Q1	$20K	Hold	85,000	–	–	﹤0.01%	1829
2021 Q4	$28K	Hold	85,000	–	–	﹤0.01%	2102
2021 Q3	$57K	Buy	+85,000	New	+$64.1K	﹤0.01%	1830

Nomura Holdings's CRXTW Position: Q4 2022 in Review

Nomura Holdings sold out of Clarus Therapeutics Holdings, Inc. Warrants (CRXTW) in Q4 2022, closing a stake of 85,000 shares.

Nomura Holdings first reported a position in CRXTW in Q3 2021 and held it in 5 quarters. The position peaked at $57K in Q3 2021. 0 funds tracked by Wall St. Rank hold CRXTW as of Q4 2022.

Nomura Holdings reported no remaining Clarus Therapeutics Holdings, Inc. Warrants position as of Q4 2022 after selling out during the quarter.
Nomura Holdings sold 85,000 Clarus Therapeutics Holdings, Inc. Warrants shares in Q4 2022.
Nomura Holdings first reported a position in Clarus Therapeutics Holdings, Inc. Warrants in Q3 2021 and held it in 5 quarters.
Nomura Holdings's Clarus Therapeutics Holdings, Inc. Warrants position peaked at $57K in Q3 2021.
0 funds tracked by Wall St. Rank held Clarus Therapeutics Holdings, Inc. Warrants as of Q4 2022.

Based on Nomura Holdings's 13F filing for Q4 2022, filed 14 Feb 2023.